
CJC-1295 No DAC
10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.
Free U.S. shipping $175+

Thymosin alpha-1 is a 28-amino-acid acetylated peptide originally isolated from thymic tissue extract.
Published laboratory research characterizes it as a modulator of immune-cell signaling, with reported interactions at toll-like receptors on dendritic cells and other antigen-presenting populations. It is used as a research reagent for studying innate immune activation and thymic peptide biology in preclinical models.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Thymosin Alpha-1 was isolated from thymic extracts in the 1970s by researchers at Albert Einstein College of Medicine, becoming one of the foundational thymic peptides in immunology research.
Synthetic Tα1 has since been widely used as a reference immunopeptide.

10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.

5/5 mg
Combined GHRH analog and secretagogue receptor agonist preparation for dual-input pituitary research.

5 mg
GHRH analog with Drug Affinity Complex modification for extended-duration receptor research.

10 mg
Second-generation growth hormone releasing peptide studied as a ghrelin receptor agonist reference.